Alzheimer’s Association “Facts and Figures 2014”: Women are at the epicenter of Alzheimer’s
The new 2014 Alzheimer’s Association Facts and Figures inlcudes a special report on the toll that Alzheimer’s takes on women in the US. The report states that almost two-thirds of American seniors with Alzheimer’s are women, and points out that women are more likely to get Alzheimer’s than breast cancer (although women’s health usually focuses on the latter).
Alzheimer’s ranked as third-leading cause of death
An article in the Washington Post draws attention to a new study that ranks Alzheimer’s disease as the third-leading cause of death in the US (after heart disease and cancer). Previous figures that ranked it as the sixth-leading cause are claimed to be grossly underestimated. The researchers (at Rush Alzheimer’s Disease Center, Chicago) show that death certificates often state immediate causes of death, not taking into account the underlying cause.
Alzheimer’s Disease International: Global Impact of Dementia Underestimated by 15-17%
In a Policy Brief for Heads of Government published ahead of the G8 Dementia Summit on 11 December, Alzheimer’s Disease International (ADI) states that previous figures from a previous report published 2009 are underestimated by 15-17%. A more comprehensive review of dementia prevalence in China and sub-Saharan Africa accounts for most of the increase.
The new figures now states that 44 million live with dementia today (2013), reaching 76 million in 2030 (up 15%) and 135 million by 2050 (up17% from previous report). The report concludes that “dementia is one of the biggest global public health challenges facing our generation.”
Alzheimer’s disease is by far the most common form of neurodegenerative disease, accounting for 60-80% of all dementia cases.
Alzheimer’s Disease International releases the World Alzheimer Report 2013
Founded in 1984, Alzheimer’s Disease International (ADI) is the international federation of 79 different Alzheimer associations around the world. ADI publishes the World Alzheimer Report annually, each report focusing on different aspects of the disease. The 2013 report released in September is entitled “Journey of Caring: An analysis of long-term care for dementia”. It is themed around the burden associated with long-term dementia care, stating that the total number of older people with care needs will increase from 101 to 277 million between 2010 and 2050, and that 80% of the elderly in nursing homes have dementia.
Alzinova profiled in ”Kemivärlden Biotech” (a Swedish trade journal)
The October issue (no. 10, 2013) of the Swedish magazine ”Kemivärlden Biotech” profiles Alzinova as one of five companies in an article entitled Tomorrow’s Biotech Companies.
“Kemivärlden Biotech” is the largest chemistry and biotech trade journal in the Nordic countries. It covers both regional and international developments within these two sectors, in addition to being the official magazine of the Swedish Chemical Society.
Alzinova will be at BIO-Europe in Vienna, 4-6 November
Meet Alzinova at the Nordic Life Science Days, 14-15 October
Alzinova will attend the Nordic Life Science Days set to take place at the Stockholm Waterfront Congress Centre, 14-15 October 2013.
Alzinova to attend BioPharm America™ 2013
Data on Alzinova’s AβCC technology published in PLOS ONE
Data supporting Alzinova’s technology was published online 2 July, 2013, in PLOS ONE.
Alzinova is featured in “Fokus: Forskning och Utveckling” (in Swedish)
New Alzheimer’s Disease Facts and Figures Now Published
The Alzheimer’s Association 2013 Alzheimer’s Disease Facts and Figures is a statistical resource for US data related to Alzheimer’s disease and other dementias. The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer’s care, support and research (www.alz.org).
The report dated March 19 provides new statistics on the impact of Alzheimer’s disease in the United States.